J&J's ketoconazole 1% shampoo
Rx-to-OTC switch application will be reviewed by joint meeting of the Nonprescription Drugs and Dermatologic Drugs Advisory Committees beginning at 1 p.m. on Feb. 16. J&J's Janssen subsidiary markets a ketoconazole 2% shampoo under the Nizoral trade name. The company recently has been running direct-to- consumer print ads for Nizoral
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth